Fired Zimbabwe state doctors reject offer to return to work

Zimbabwe state doctors who were fired for going on strike have rejected a government offer to return to work, their union said on Friday.

AstraZeneca's Imfinzi gets speedy FDA review for small cell lung cancer

British drugmaker AstraZeneca Plc said on Friday its immunotherapy cancer treatment Imfinzi has been granted a speedy review by the U.S. medicines watchdog for the treatment of a particularly aggressive type of lung cancer.

Samoa measles toll hits 42 as nations dispatch medical teams, supplies

More nations were flying medical staff and supplies to Samoa on Friday to battle a measles outbreak that prompted the Pacific island nation to declare a state of emergency this month, as the death toll rose to 42, most of them children younger than four.

Four killed in attacks against Ebola response centers in Congo

Militia fighters in eastern Congo killed four people and injured several others in attacks on two Ebola response centers on Thursday, in what responders described as a serious setback to efforts to contain the epidemic.

Novartis's $90 million Swiss factory to help solve cell therapy bottleneck

Swiss drugmaker Novartis's new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of its cell therapy Kymriah for cancer in 2020.

Inducing labor at 41 weeks safer than 'wait and see' approach

(Reuters Health) - For late-term pregnancies, inducing labor at 41 weeks may be safer than waiting until week 42, a large Swedish study suggests.

No evidence stretching prevents running injuries

(Reuters Health) - It's a common and persistent myth that static stretching improves running performance and decreases the risk of injuries, researchers say.

Large waist in normal-weight elderly tied to higher dementia risk

(Reuters Health) - Older adults with normal weight but a wider waist may be at a higher risk of developing dementia, a Korean study suggests.

ImmuPharma licenses lupus drug Lupuzor to Avion in the United States

British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals.

China reports fourth case of plague this month

Chinese health authorities on Thursday reported a fresh case of bubonic plague in the country's northern Inner Mongolia region, bringing the total number of plague cases to four since the beginning of the month.

Massachusetts adopts tough ban on flavored vaping, tobacco products

Massachusetts on Wednesday adopted the country's toughest ban on the sale of flavored tobacco and vaping products, including menthol cigarettes, in response to a rise in youth vaping and an outbreak of vaping-related serious lung injuries.

Related Videos

Swift takes high road, makes history, at AMAs

Thieves grab jewels, treasures worth 'up to a billion euros' in Dresden

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS